Literature DB >> 22293176

Direct and efficient cellular transformation of primary rat mesenchymal precursor cells by KSHV.

Tiffany Jones1, Fengchun Ye, Roble Bedolla, Yufei Huang, Jia Meng, Liwu Qian, Hongyi Pan, Fuchun Zhou, Rosalie Moody, Brent Wagner, Mazen Arar, Shou-Jiang Gao.   

Abstract

Infections by viruses are associated with approximately 12% of human cancer. Kaposi's sarcoma-associated herpesvirus (KSHV) is causally linked to several malignancies commonly found in AIDS patients. The mechanism of KSHV-induced oncogenesis remains elusive, due in part to the lack of an adequate experimental system for cellular transformation of primary cells. Here, we report efficient infection and cellular transformation of primary rat embryonic metanephric mesenchymal precursor cells (MM cells) by KSHV. Cellular transformation occurred at as early as day 4 after infection and in nearly all infected cells. Transformed cells expressed hallmark vascular endothelial, lymphatic endothelial, and mesenchymal markers and efficiently induced tumors in nude mice. KSHV established latent infection in MM cells, and lytic induction resulted in low levels of detectable infectious virions despite robust expression of lytic genes. Most KSHV-induced tumor cells were in a latent state, although a few showed heterogeneous expression of lytic genes. This efficient system for KSHV cellular transformation of primary cells might facilitate the study of growth deregulation mechanisms resulting from KSHV infections.

Entities:  

Mesh:

Year:  2012        PMID: 22293176      PMCID: PMC3287217          DOI: 10.1172/JCI58530

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  Expression of the CD34 gene in vascular endothelial cells.

Authors:  L Fina; H V Molgaard; D Robertson; N J Bradley; P Monaghan; D Delia; D R Sutherland; M A Baker; M F Greaves
Journal:  Blood       Date:  1990-06-15       Impact factor: 22.113

2.  Immunocytochemical profile of Kaposi's sarcoma cells: their reactivity to a panel of antibodies directed against different tissue cell markers.

Authors:  G Massarelli; C A Scott; M Ibba; F Tanda; A Cossu
Journal:  Appl Pathol       Date:  1989

3.  Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo.

Authors:  Feng-Qi An; Hope Merlene Folarin; Nicole Compitello; Justin Roth; Stanton L Gerson; Keith R McCrae; Farnaz D Fakhari; Dirk P Dittmer; Rolf Renne
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

4.  KSHV sequences in biopsies and cultured spindle cells of epidemic, iatrogenic and Mediterranean forms of Kaposi's sarcoma.

Authors:  M G Aluigi; A Albini; S Carlone; L Repetto; R De Marchi; A Icardi; M Moro; D Noonan; R Benelli
Journal:  Res Virol       Date:  1996 Sep-Oct

5.  Murine metanephric mesenchyme possesses characteristics of vascular endothelial cells in vitro.

Authors:  Joichi Usui; Risa Yamada; Katsuyoshi Kanemoto; Akio Koyama; Michio Nagata
Journal:  Nephron Exp Nephrol       Date:  2005-11-11

6.  Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8.

Authors:  A V Moses; K N Fish; R Ruhl; P P Smith; J G Strussenberg; L Zhu; B Chandran; J A Nelson
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

7.  Characterization of in vitro culture of HIV-negative Kaposi's sarcoma-derived cells. In vitro responses to alfa interferon.

Authors:  C Lebbé; P de Crémoux; G Millot; M P Podgorniak; O Verola; R Berger; P Morel; F Calvo
Journal:  Arch Dermatol Res       Date:  1997-06       Impact factor: 3.017

8.  The global health burden of infection-associated cancers in the year 2002.

Authors:  Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2006-06-15       Impact factor: 7.396

9.  Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus.

Authors:  O Flore; S Rafii; S Ely; J J O'Leary; E M Hyjek; E Cesarman
Journal:  Nature       Date:  1998-08-06       Impact factor: 49.962

10.  KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway.

Authors:  S J Gao; C Boshoff; S Jayachandra; R A Weiss; Y Chang; P S Moore
Journal:  Oncogene       Date:  1997-10-16       Impact factor: 9.867

View more
  66 in total

1.  K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus.

Authors:  Lisa Steinbrück; Montse Gustems; Stephanie Medele; Thomas F Schulz; Dominik Lutter; Wolfgang Hammerschmidt
Journal:  J Virol       Date:  2015-05-06       Impact factor: 5.103

2.  Oncogenic Kaposi's Sarcoma-Associated Herpesvirus Upregulates Argininosuccinate Synthase 1, a Rate-Limiting Enzyme of the Citrulline-Nitric Oxide Cycle, To Activate the STAT3 Pathway and Promote Growth Transformation.

Authors:  Tingting Li; Ying Zhu; Fan Cheng; Chun Lu; Jae U Jung; Shou-Jiang Gao
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

3.  Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: identification of sirtuin 1 as a regulator of the KSHV life cycle.

Authors:  Qiuhua Li; Meilan He; Fuchun Zhou; Fengchun Ye; Shou-Jiang Gao
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

4.  Kaposi's sarcoma-associated herpesvirus infection promotes differentiation and polarization of monocytes into tumor-associated macrophages.

Authors:  Natarajan Bhaskaran; Santosh K Ghosh; Xiaolan Yu; Sanhai Qin; Aaron Weinberg; Pushpa Pandiyan; Fengchun Ye
Journal:  Cell Cycle       Date:  2017-07-27       Impact factor: 4.534

5.  Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone.

Authors:  Kevin F Brulois; Heesoon Chang; Amy Si-Ying Lee; Armin Ensser; Lai-Yee Wong; Zsolt Toth; Sun Hwa Lee; Hye-Ra Lee; Jinjong Myoung; Don Ganem; Tae-Kwang Oh; Jihyun F Kim; Shou-Jiang Gao; Jae U Jung
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

Review 6.  Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy.

Authors:  Dirk P Dittmer; Blossom Damania
Journal:  J Clin Invest       Date:  2016-09-01       Impact factor: 14.808

7.  Viral cyclin promotes KSHV-induced cellular transformation and tumorigenesis by overriding contact inhibition.

Authors:  Tiffany Jones; Suzane Ramos da Silva; Roble Bedolla; Fengchun Ye; Fuchun Zhou; Shou-Jiang Gao
Journal:  Cell Cycle       Date:  2014-01-13       Impact factor: 4.534

8.  The role of Kaposi's sarcoma-associated herpesvirus infection in the proliferation of human bladder cancer cells.

Authors:  Jisu Lee; Hyungtaek Jeon; Seung-Min Yoo; Jinsung Park; Myung-Shin Lee
Journal:  Tumour Biol       Date:  2015-09-21

9.  Latent Kaposi's sarcoma-associated herpesvirus infection in bladder cancer cells promotes drug resistance by reducing reactive oxygen species.

Authors:  Suhyuk Lee; Jaehyuk Jang; Hyungtaek Jeon; Jisu Lee; Seung-Min Yoo; Jinsung Park; Myung-Shin Lee
Journal:  J Microbiol       Date:  2016-10-29       Impact factor: 3.422

Review 10.  Recent advances in the study of Kaposi's sarcoma-associated herpesvirus replication and pathogenesis.

Authors:  Denis Avey; Brittany Brewers; Fanxiu Zhu
Journal:  Virol Sin       Date:  2015-04-23       Impact factor: 4.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.